ClinicalTrials.govpublic full text
A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib
carcinoma, hepatocellular, liver neoplasms, antineoplastic agents, genexol-pm, neoplasms by site, sorafenib, liver diseases, digestive system neoplasms, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1007286
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.